North China Pharmaceutical Co., Ltd. (600812)
Market Open
10 Aug, 06:57
SSE SSE Primary ¥
5. 02
+0.06
+1.2097%
¥
10.72B Market Cap
- P/E Ratio
0.04% Div Yield
30.09M Volume
- Eps
¥ 4.96
Previous Close Want to track 600812 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.02 |
| | | - | 0.01 |
| | | - | 0.01 |
| | | - | 0.02 |
| | | - | - |
| | | - | 0.01 |
| | | - | 0.01 |
| | | - | 0.01 |
| | | - | 0.01 |
| | | - | 0 |
| | | - | 0 |
| | | - | 0 |
| | | - | 0 |
| | | - | 0 |
| | | - | 0 |
| | | - | 0.08 |
600812 Earnings Reports FAQ
What is the earnings per share (EPS) for 600812?
EPS data for 600812 is currently not available, as North China Pharmaceutical Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 11 years, the earnings growth rate has been approximately -36.4%, reflecting the 600812's performance and SSE market conditions.
When is the next earnings release date?
North China Pharmaceutical Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for North China Pharmaceutical Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 600812 at this time, as North China Pharmaceutical Co., Ltd has no recent EPS data to calculate it.
